Loading...

Annika Herlemann, MD

TitleAssistant Professor
SchoolUCSF School of Medicine
DepartmentUrology
Address550 16th. Street
San Francisco CA 94158
Phone415-885-7748
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Ludwig-Maximilians-University, Munich, GermanyM.D.2012School of Medicine

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Yu Q, Gratzke C, Wang Y, Herlemann A, Sterr CM, Rutz B, Ciotkowska A, Wang X, Strittmatter F, Stief CG, Hennenberg M. Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3. Br J Pharmacol. 2018 Mar 25. PMID: 29574791.
      View in: PubMed
    2. Schmidt-Hegemann NS, Fendler WP, Ilhan H, Herlemann A, Buchner A, Stief C, Eze C, Rogowski P, Li M, Bartenstein P, Ganswindt U, Belka C. Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy. Radiat Oncol. 2018 Mar 02; 13(1):37. PMID: 29499730.
      View in: PubMed
    3. Chaloupka M, Herlemann A, D'Anastasi M, Cyran CC, Ilhan H, Gratzke C, Stief CG. 68Gallium-Prostate-Specific Membrane Antigen PET/Computed Tomography for Primary and Secondary Staging in Prostate Cancer. Urol Clin North Am. 2017 Nov; 44(4):557-563. PMID: 29107272.
      View in: PubMed
    4. Herlemann A, Washington SL, Eapen RS, Cooperberg MR. Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier. Urol Clin North Am. 2017 Nov; 44(4):547-555. PMID: 29107271.
      View in: PubMed
    5. Chaloupka M, Herlemann A, Spek A, Gratzke C, Stief C. [Cytoreductive, radical prostatectomy in metastatic prostate cancer]. Urologe A. 2017 Nov; 56(11):1430-1434. PMID: 28983651.
      View in: PubMed
    6. Herlemann A, Kretschmer A, Buchner A, Karl A, Tritschler S, El-Malazi L, Fendler WP, Wenter V, Ilhan H, Bartenstein P, Stief CG, Gratzke C. Salvage lymph node dissection after 68Ga-PSMA or 18F-FEC PET/CT for nodal recurrence in prostate cancer patients. Oncotarget. 2017 Oct 13; 8(48):84180-84192. PMID: 29137414.
      View in: PubMed
    7. Herlemann A, Keller P, Schott M, Tamalunas A, Ciotkowska A, Rutz B, Wang Y, Yu Q, Waidelich R, Strittmatter F, Stief CG, Gratzke C, Hennenberg M. Inhibition of smooth muscle contraction and ARF6 activity by the inhibitor for cytohesin GEFs, secinH3, in the human prostate. Am J Physiol Renal Physiol. 2018 01 01; 314(1):F47-F57. PMID: 28855187.
      View in: PubMed
    8. Wenter V, Herlemann A, Fendler WP, Ilhan H, Tirichter N, Bartenstein P, Stief CG, la Fougère C, Albert NL, Rominger A, Gratzke C. Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy. Oncotarget. 2017 Jul 04; 8(27):44131-44140. PMID: 28484088.
      View in: PubMed
    9. Herlemann A, Horst D, D'Anastasi M, Kretschmer A, Stief CG, Gratzke C. [Primary prostatic sarcoma - a rare malignancy]. Urologe A. 2017 Jul; 56(7):857-860. PMID: 28349187.
      View in: PubMed
    10. Herlemann A, Wegner K, Roosen A, Buchner A, Weinhold P, Bachmann A, Stief CG, Gratzke C, Magistro G. "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP). World J Urol. 2017 Nov; 35(11):1777-1782. PMID: 28516315.
      View in: PubMed
    11. Herlemann A, Buchner A, Kretschmer A, Apfelbeck M, Stief CG, Gratzke C, Tritschler S. Postoperative upgrading of prostate cancer in men =75 years: a propensity score-matched analysis. World J Urol. 2017 Oct; 35(10):1517-1524. PMID: 28493044.
      View in: PubMed
    12. Herlemann A, Cowan JE, Carroll PR, Cooperberg MR. Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy. Eur Urol. 2018 Feb; 73(2):215-223. PMID: 28499617.
      View in: PubMed
    13. Eapen RS, Herlemann A, Washington SL, Cooperberg MR. Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging. Curr Opin Urol. 2017 May; 27(3):205-209. PMID: 28221220.
      View in: PubMed
    14. Jokisch JF, Herlemann A, Weinhold P, Magistro G, Stief CG, Gratzke C. [Management of benign prostatic hyperplasia (BPH)]. MMW Fortschr Med. 2017 May; 159(9):58-64. PMID: 28509060.
      View in: PubMed
    15. Kretschmer A, Herlemann A, Stief CG, Gratzke C. [When is surgical treatment indicated in metastatic prostate cancer and what is the scientific rationale?] Urologe A. 2017 May; 56(5):599-603. PMID: 28314971.
      View in: PubMed
    16. Spek A, Herlemann A, Gratzke C, Stief CG. [Radical prostatectomy as part of a multimodal concept for patients with prostate cancer and bone metastases at initial diagnosis]. Urologe A. 2017 May; 56(5):595-598. PMID: 28314969.
      View in: PubMed
    17. Hennenberg M, Tamalunas A, Wang Y, Keller P, Schott M, Strittmatter F, Herlemann A, Yu Q, Rutz B, Ciotkowska A, Stief CG, Gratzke C. Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region. Eur J Pharmacol. 2017 May 15; 803:39-47. PMID: 28315343.
      View in: PubMed
    18. Herlemann A, Kretschmer A, Apfelbeck M, Tritschler S, Fendler W, Bartenstein P, Reiser M, Stief CG, Gratzke C. [Prostate Cancer - Update 2017]. MMW Fortschr Med. 2017 Mar; 159(4):58-65. PMID: 28265958.
      View in: PubMed
    19. Hennenberg M, Acevedo A, Wiemer N, Kan A, Tamalunas A, Wang Y, Yu Q, Rutz B, Ciotkowska A, Herlemann A, Strittmatter F, Stief CG, Gratzke C. Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction is Sufficient to Replace a1 -Adrenergic Tension in the Human Prostate. Prostate. 2017 May; 77(7):697-707. PMID: 28116771.
      View in: PubMed
    20. Kretschmer A, Buchner A, Grabbert M, Sommer A, Herlemann A, Stief CG, Bauer RM. Perioperative patient education improves long-term satisfaction rates of low-risk prostate cancer patients after radical prostatectomy. World J Urol. 2017 Aug; 35(8):1205-1212. PMID: 28093628.
      View in: PubMed
    21. Wang Y, Gratzke C, Tamalunas A, Rutz B, Ciotkowska A, Strittmatter F, Herlemann A, Janich S, Waidelich R, Liu C, Stief CG, Hennenberg M. Smooth muscle contraction and growth of stromal cells in the human prostate are both inhibited by the Src family kinase inhibitors, AZM475271 and PP2. Br J Pharmacol. 2016 12; 173(23):3342-3358. PMID: 27638545.
      View in: PubMed
    22. Hennenberg M, Schott M, Kan A, Keller P, Tamalunas A, Ciotkowska A, Rutz B, Wang Y, Strittmatter F, Herlemann A, Yu Q, Stief CG, Gratzke C. Inhibition of Adrenergic and Non-Adrenergic Smooth Muscle Contraction in the Human Prostate by the Phosphodiesterase 10-Selective Inhibitor TC-E 5005. Prostate. 2016 Nov; 76(15):1364-74. PMID: 27418235.
      View in: PubMed
    23. Apfelbeck M, Herlemann A, Stief CG, Gratzke C. [Focal therapy of prostate cancer in Germany]. Urologe A. 2016 May; 55(5):584-92. PMID: 27142799.
      View in: PubMed
    24. Magistro G, Marcon J, Beck V, Herlemann A, Stief CG, Gratzke C. [Current Aspects on the Pathogenesis of Urinary Tract Infections]. Aktuelle Urol. 2016 05; 47(3):203-9. PMID: 27008434.
      View in: PubMed
    25. Herlemann A, Stief CG. [Active surveillance for low-risk prostate cancer]. Urologe A. 2016 Feb; 55(2):269-81. PMID: 26831055.
      View in: PubMed
    26. Herlemann A, Wenter V, Kretschmer A, Thierfelder KM, Bartenstein P, Faber C, Gildehaus FJ, Stief CG, Gratzke C, Fendler WP. 68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer. Eur Urol. 2016 10; 70(4):553-557. PMID: 26810345.
      View in: PubMed
    27. Preis L, Herlemann A, Adam RM, Dietz HG, Kappler R, Stehr M. Platelet Derived Growth Factor Has a Role in Pressure Induced Bladder Smooth Muscle Cell Hyperplasia and Acts in a Paracrine Way. J Urol. 2015 Dec; 194(6):1797-805. PMID: 26055827.
      View in: PubMed
    28. Herlemann A, Strittmatter F, Stief CG, Gratzke C. [Management of benign prostate syndrome]. MMW Fortschr Med. 2013 Aug 22; 155(14):39-42. PMID: 24006594.
      View in: PubMed
    29. Weinhold P, Magistro G, Strittmatter F, Herlemann A, Stief CG, Gratzke C, Roosen A. [Etiology and diagnostics of the benign prostate syndrom]. MMW Fortschr Med. 2013 Aug 22; 155(14):35-8. PMID: 24006593.
      View in: PubMed
    30. Herlemann A, Strittmatter F, Buchner A, Karl A, Reich O, Bachmann A, Stief CG, Gratzke C. Virtual reality systems in urologic surgery: an evaluation of the GreenLight simulator. Eur Urol. 2013 Oct; 64(4):687-8. PMID: 23790439.
      View in: PubMed
    31. Herlemann A, Gratzke C, Andersson KE, Sievert KD. [Medicinal therapy of benign prostate syndrome with phosphodiesterase-5 inhibitors]. Urologe A. 2013 Feb; 52(2):204-11. PMID: 23417046.
      View in: PubMed
    32. Seitz M, Herlemann A, Magistro G, Stief CG. [Diagnostics of benign prostate syndrome]. Urologe A. 2013 Feb; 52(2):193-6. PMID: 23417045.
      View in: PubMed
    33. Khoder WY, Gratzke C, Haseke N, Herlemann A, Stief CG, Becker AJ. Laparoscopic marsupialisation of pelvic lymphoceles in different anatomic locations following radical prostatectomy. Eur Urol. 2012 Oct; 62(4):640-8. PMID: 22717549.
      View in: PubMed
    Annika's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP